<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00947518</url>
  </required_header>
  <id_info>
    <org_study_id>10/2004</org_study_id>
    <nct_id>NCT00947518</nct_id>
  </id_info>
  <brief_title>Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants</brief_title>
  <official_title>Does Skin Cleansing With Chlorhexidine Affect Skin Condition, Temperature and Colonization in Hospitalized Preterm Low Birth Weight Infants?: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine if single skin cleansing with 0.25% chlorhexidine
      affects skin condition, temperature, and bacterial colonization in stable preterm (28-36
      weeks gestational age) low birth weight (1001-2000 g) infants admitted in a health facility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infections are the leading cause of death in neonates admitted to hospital - studies from
      developing countries suggest that about 25-71% of deaths occurring in neonatal intensive care
      units are secondary to infections.Such high infection-related mortality mandates an urgent
      implementation of simple and effective measures to prevent the occurrence of infections in
      these units.

      The majority of neonatal infections occur in the first two weeks of life, when the epidermal
      barrier is immature and functionally compromised. Topical application of antiseptics until
      the skin matures could theoretically prevent skin colonization and reduce the incidence of
      systemic infections in neonates. Chlorhexidine, a broad-spectrum antiseptic used frequently
      for umbilical cord care in neonates, is now being evaluated for topical application to the
      skin. Hospital-based studies, involving predominantly term infants, have shown reductions in
      skin flora8 and a reduction in the incidence of sepsis following topical chlorhexidine
      application. In a community-based study in Nepal, a single skin cleansing with 0.25%
      chlorhexidine resulted in reduction in mortality among low birth weight infants; though the
      mechanism of the impact could not be determined, it was presumably due to increased
      susceptibility to transcutaneous sepsis in the low birth weight group.

      Since the risk of infection in neonates is inversely related to their gestation, it is
      essential to evaluate the effect and the mechanism of such intervention in preterm neonates.
      These infants are, however, more prone to develop skin reactions following use of topical
      antiseptics. Preterm infants are also more prone to develop hypothermia following
      bathing/cleansing with antiseptic solution(s).

      Since few studies have evaluated the effects of topical application of chlorhexidine in
      preterm infants admitted in a health care facility, we conducted the present study to examine
      if single skin cleansing with 0.25% chlorhexidine immediately after birth affects skin
      condition, temperature, and colonization in hospitalized preterm low birth weight infants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">February 2006</completion_date>
  <primary_completion_date type="Actual">February 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Median Skin Condition Score on the 9-point Skin Condition Grading Scale Adapted by Darmstadt From Lane et al</measure>
    <time_frame>At 24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin Temperature at 30 Min After Intervention</measure>
    <time_frame>at 30 min after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Positive Skin Culture at Axilla</measure>
    <time_frame>24 hours after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Clinical and Culture Positive Sepsis</measure>
    <time_frame>First week of life.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Neonatal Sepsis</condition>
  <condition>Low Birth Weight</condition>
  <arm_group>
    <arm_group_label>Chlorhexidine skin cleansing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wiping the skin (except the face) once immediately after birth using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline skin cleansing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Wiping the skin (except the face) once immediately after birth using baby wipes containing normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No skin cleansing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No skin application</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine</intervention_name>
    <description>Baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)</description>
    <arm_group_label>Chlorhexidine skin cleansing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Cleansing the skin (except the face)with baby wipes containing normal saline</description>
    <arm_group_label>Saline skin cleansing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants of 28 to 36 weeks' gestation

          -  Birth weights between 1001 and 2000 g

        Exclusion Criteria:

          -  Infants with one minute Apgar score &lt; 4

          -  Hemodynamic instability

          -  Congenital malformations

          -  Generalized skin disorder and

          -  Infants who need respiratory support (continuous positive airway pressure and/or
             intermittent mandatory ventilation) in the first 2-3 hours of life
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mari J Sankar, MD DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinod K Paul, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashok K Deorari, MD MNAMS</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gary L Darmstadt, MD MS</last_name>
    <role>Study Chair</role>
    <affiliation>Department of International Health, Bloomberg School of Public Health, Johns Hopkins University</affiliation>
  </overall_official>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2009</study_first_submitted>
  <study_first_submitted_qc>July 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2009</study_first_posted>
  <results_first_submitted>April 20, 2009</results_first_submitted>
  <results_first_submitted_qc>July 27, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 28, 2009</results_first_posted>
  <last_update_submitted>July 27, 2009</last_update_submitted>
  <last_update_submitted_qc>July 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>M Jeeva Sankar</name_title>
    <organization>Department of Pediatrics, AIIMS, New Delhi</organization>
  </responsible_party>
  <keyword>chlorhexidine</keyword>
  <keyword>preterm</keyword>
  <keyword>newborn</keyword>
  <keyword>skin condition</keyword>
  <keyword>temperature</keyword>
  <keyword>skin flora</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>from August 2005 to February 2006 at the tertiary level neonatal intensive care unit of All India Institute of Medical Sciences, New Delhi</recruitment_details>
      <pre_assignment_details>Infants with one minute Apgar score &lt;4, hemodynamic instability, congenital malformations, generalized skin disorder and who needed respiratory support (continuous positive airway pressure and/or intermittent mandatory ventilation) were excluded</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Chlorhexidine Skin Cleansing</title>
          <description>Wiping the skin (except the face) using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)</description>
        </group>
        <group group_id="P2">
          <title>Saline Skin Cleansing</title>
          <description>Wiping the skin (except the face) using baby wipes containing normal saline</description>
        </group>
        <group group_id="P3">
          <title>No Skin Cleansing</title>
          <description>No skin application</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Chlorhexidine Skin Cleansing</title>
          <description>Wiping the skin (except the face) using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)</description>
        </group>
        <group group_id="B2">
          <title>Saline Skin Cleansing</title>
          <description>Wiping the skin (except the face) using baby wipes containing normal saline</description>
        </group>
        <group group_id="B3">
          <title>No Skin Cleansing</title>
          <description>No skin application</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestation (weeks)</title>
          <description>Estimated gestational age in completed weeks</description>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33" lower_limit="28" upper_limit="36"/>
                    <measurement group_id="B2" value="33" lower_limit="28" upper_limit="36"/>
                    <measurement group_id="B3" value="32.5" lower_limit="28" upper_limit="36"/>
                    <measurement group_id="B4" value="33" lower_limit="28" upper_limit="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Median Skin Condition Score on the 9-point Skin Condition Grading Scale Adapted by Darmstadt From Lane et al</title>
        <description>The skin condition grading scale assesses the condition of the skin on the abdomen and dorsum of the hands/feet based on drying, erythema, crusting, oozing, etc. on a continuous scale from 1 (normal) to 9 (vesicles or pustules)</description>
        <time_frame>At 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine Skin Cleansing</title>
            <description>Wiping the skin (except the face) using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)</description>
          </group>
          <group group_id="O2">
            <title>Saline Skin Cleansing</title>
            <description>Wiping the skin (except the face) using baby wipes containing normal saline</description>
          </group>
          <group group_id="O3">
            <title>No Skin Cleansing</title>
            <description>No skin application</description>
          </group>
        </group_list>
        <measure>
          <title>Median Skin Condition Score on the 9-point Skin Condition Grading Scale Adapted by Darmstadt From Lane et al</title>
          <description>The skin condition grading scale assesses the condition of the skin on the abdomen and dorsum of the hands/feet based on drying, erythema, crusting, oozing, etc. on a continuous scale from 1 (normal) to 9 (vesicles or pustules)</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O3" value="1" lower_limit="1" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.99</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Skin Temperature at 30 Min After Intervention</title>
        <description>Axillary skin temperature measured by a clinical thermometer kept in axilla for 3 minutes</description>
        <time_frame>at 30 min after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine Skin Cleansing</title>
            <description>Wiping the skin (except the face) using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)</description>
          </group>
          <group group_id="O2">
            <title>Saline Skin Cleansing</title>
            <description>Wiping the skin (except the face) using baby wipes containing normal saline</description>
          </group>
          <group group_id="O3">
            <title>No Skin Cleansing</title>
            <description>No skin application</description>
          </group>
        </group_list>
        <measure>
          <title>Skin Temperature at 30 Min After Intervention</title>
          <description>Axillary skin temperature measured by a clinical thermometer kept in axilla for 3 minutes</description>
          <units>Degree Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.6" spread="0.2"/>
                    <measurement group_id="O2" value="36.6" spread="0.12"/>
                    <measurement group_id="O3" value="36.7" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.46</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Positive Skin Culture at Axilla</title>
        <description>Occurrence of any bacterial flora irrespective of the colony count in the skin swabs from axilla at 24 hrs after intervention</description>
        <time_frame>24 hours after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine Skin Cleansing</title>
            <description>Wiping the skin (except the face) using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)</description>
          </group>
          <group group_id="O2">
            <title>Saline Skin Cleansing</title>
            <description>Wiping the skin (except the face) using baby wipes containing normal saline</description>
          </group>
          <group group_id="O3">
            <title>No Skin Cleansing</title>
            <description>No skin application</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Positive Skin Culture at Axilla</title>
          <description>Occurrence of any bacterial flora irrespective of the colony count in the skin swabs from axilla at 24 hrs after intervention</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.06</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Clinical and Culture Positive Sepsis</title>
        <time_frame>First week of life.</time_frame>
        <posting_date>09/2009</posting_date>
      </outcome>
    </outcome_list>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mari Jeeva Sankar</name_or_title>
      <organization>Department of Pediatrics, All India Institute of Medical Sciences, New Delhi</organization>
      <phone>+91-11-26594372</phone>
      <email>jeevasankar@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

